21 February 2012
Six new assays have been added to Binding Site’s SPAPLUS Specialist Protein Analyser menu: IgG in CSF (cerebrospinal fluid), IgA CSF, IgM CSF and albumin CSF plus C1 inactivator (C1 inhibitor) in serum and plasma and transferrin in serum. All six assays are fully automated, easy to use and provide quantitative results to aid the assessment of a patient’s immune system (CSF assays), the investigation of hereditary angioedema (C1 inactivator) and iron deficiency anaemia (transferrin).The SPAPLUS is ideal for Binding Site’s specialist protein assays and has been designed to bring together instrument, reagents and exceptional support as a package from a specialist protein focused supplier.
The SPAPLUS is a compact, turbidimetric platform for specialist protein testing. The fully automated SPAPLUS system enables laboratories to maintain the quality of results and high throughput required for specialised protein assays. It can be placed alongside the laboratory’s main-line analysers or in other areas of the laboratory.
Pre-programmed protocols developed and manufactured by Binding Site provide highly sensitive and reproducible results that match or have greater sensitivity than nephelometry. The modular design with intuitive Windows® based software makes the SPAPLUS very easy to use. It is engineered to a high standard demonstrating excellent reliability with minimal daily, weekly and monthly maintenance procedures.
These new additions complement the panel of assays currently available on SPAPLUS which include Freelite® serum free light chain assays, Hevylite® immunoglobulin heavy chain/light chain assays, IgG, IgA, IgM, IgD, IgG and IgA subclasses, complement C3c, C4, CH50, albumin serum, haptoglobin, prealbumin (transthyretin), cystatin C and beta-2 microglobulin. SPAPLUS has an expanding menu of diagnostic tests related to disease state management and clinical practice guidelines. More assays will be added during 2012.
